| HOME >> BIOLOGY >> TECHNOLOGY |
$ $
-------------------------------------------------------------------------
ASSETS
Current
Cash and cash equivalents 3,326,374 3,491,511
Short-term investments 24,865,090 24,122,237
Accounts receivable 36,637 84,003
Prepaid expenses 413,811 638,540
-------------------------------------------------------------------------
28,641,912 28,336,291
Property and equipment 169,226 149,596
Intellectual property 5,085,755 5,079,805
-------------------------------------------------------------------------
33,896,893 33,565,692
-------------------------------------------------------------------------
-------------------------------------------------------------------------
LIABILITIES AND SHAREHOLDERS' EQUITY
Current
Accounts payable and accrued liabilities 2,298,064 2,616,421
-------------------------------------------------------------------------
Alberta Heritage Foundation loan - 150,000
-------------------------------------------------------------------------
Shareholders' equity
Share capital
Authorized: unlimited number of common shares
Issued: 41,120,748 (December 31, 2006 -
36,520,748) 92,708,665 83,083,271
Warrants 6,654,740 4,216,740
Contributed surplus 8,672,204 8,529,326
Deficit (76,436,7
'/>"/>
| SOURCE Oncolytics Biotech Inc. Copyright©2007 PR Newswire. All rights reserved |